Articles
Page 17 of 27
-
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P70
-
Monoamine oxidase B is associated with γ-secretase in cultured neurons and in brain
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P69 -
p53-mediated disruption of FIP200 function cause autophagic dysregulation in a SCA7 polyglutamine disease model
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P68 -
Insulin resistance and obesity: how do they affect tau pathology?
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P67 -
Sirtuin mediated neuroprotection and its association with autophagy and apoptosis: Studies employing transgenic C. elegans model
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P65 -
Misfolding and interactions of Aß proteins: Insight from single molecule experiments and computational analyses
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P64 -
The beta-secretase-derived C-terminal fragment of APP (C99): a key determinant for intraneuronal pathology in the 3xTgAD mouse
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P63 -
Early hippocampal synaptic plasticity and episodic like-memory deficits in a transgenic mouse model of Alzheimer disease - involvment of corticosterone
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P62 -
Tau-Hsp70 interaction on the single molecule level
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P61 -
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P60 -
Structure-function-relationship of the APP-E1-domain
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P59 -
Late neurodegeneration in the Tau transgenic mouse model rTg4510
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P58 -
Tauopathy-induced retinal dysfunction in the P301S mutant human tau transgenic mouse
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P57 -
Parkin acts as a transcription factor modulating presenilin-1 and presenilin-2 promoter transactivations
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P56 -
The overall structure of the multi-domain amyloid precursor protein
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P55 -
Leaky Ryanodine receptors increases Amyloid-beta load and induces memory impairments in Tg2576 mouse model of Alzheimer disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P54 -
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
Epidemiological and molecular findings suggest a relationship between Alzheimer’s disease (AD) and dyslipidemia, although the nature of this association is not well understood.
Citation: Molecular Neurodegeneration 2013 8:39 -
Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics
Mitochondrial quality control is fundamental to all neurodegenerative diseases, including the most prominent ones, Alzheimer’s Disease and Parkinsonism. It is accomplished by mitochondrial network dynamics – c...
Citation: Molecular Neurodegeneration 2013 8:32 -
Generation and characterization of individual-specific induced pluripotent cells from patient-derived lymphoblastoid cell lines
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P53 -
Ataxia-telangiectasia paradoxes: spotlight on post-zygotic chromosome instability in the brain and its contribution to neurodegeneration pathways
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P51 -
Histone deacetylase inhibition leads to neuroprotection through regulation on glial function
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P49 -
A driver or a passenger? D421-caspase cleaved tau is associated with aggregated and insoluble tau
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P47 -
Cysteine-rich domain of scavenger receptor Al modulates the efficacy of surface targeting and mediates internalization of oligomeric beta amyloid
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P43 -
β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P41 -
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O37 -
Analysis of the protein network of cholesterol homeostasis maintenance in a mouse model of Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P37 -
Abeta is prerequisite, but insufficient to cause tau phosphorylation in vivo: tau phosphorylation in APP mice by diabetes
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P35 -
Identifying dominant modifiers of mutant FUS toxicity in vivo
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O33 -
LRP1 plays a major role in the amyloid-β clearance in microglia
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P33 -
Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P31 -
Amyloid-β drives a type-1 interferon mediated neuro-inflammatory response in Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P29 -
Deciphering the role of tau in neurodegeneration using Adeno-Associated Viral (AAV) vectors to express human tau in the mouse forebrain
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P27 -
Transmission of alpha-synuclein in Parkinson’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O25 -
Analysis of TDP-43 and its binding partners in neurodegenerative diseases
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P23 -
Prion-like aspects of cerebral amyloidosis
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O21 -
The role of SorLA in neurotrophic activity and complex behavior
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P19 -
Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P16 -
In situstudies of protein aggregation kinetics with multiparametric and superresolution imaging
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O15 -
Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P14 -
Regulation of mitochondrial function by PINK1, Parkin and DJ-1
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O13 -
Using Caenorhabditis elegans to fight human neurodegenerative diseases
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P12 -
Endogenous and exogenous regulation of gamma-secretase
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O10 -
The pro-neurotrophin receptor sortilin is a major neuronal APOE receptor for catabolism of amyloid-β peptide in the brain
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P10 -
Regulation of dynamic BACE1 trafficking in neurons
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O8 -
Development of a paradigm to investigate mechanisms of divided and selective attention impairment in the rodent models of Alzheimer’s disease
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P6 -
Proteomics in neurons and animals: substrates and therapeutic potential of alpha-and beta-secretase
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O6 -
A new transgenic mouse model for studying the neurotoxicity of spermine oxidase dosage in the response to excitotoxic injury
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P4 -
Role of APP in neuronal function
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O4 -
The composition of the γ-secretase complex defines its Aβ product profile
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):P2 -
Decoding Alzheimer’s in the age of genome-wide analyses
Citation: Molecular Neurodegeneration 2013 8(Suppl 1):O1
Follow
- ISSN: 1750-1326 (electronic)